Trial intelligence / Profile preview

Gender Differences in Acute Effects of THC

NCT02811510Phase 1Recruiting

Sponsor
Yale University
Start
Jun 2016
Primary completion
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial comparing THC with Placebo (2 arms). Primary endpoints: Change from Baseline: Rewarding Effects measured by Visual Analog Scale (VAS) at 300 months and Change from Baseline: Verbal Learning: Measured by Rey Auditory Verbal Learning Test (RAVLT) at 80 months. Started Jun 2016; status: recruiting.

02

Drugs

dronabinol

Beyond the preview

Go deeper on NCT02811510.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02811510.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call